What is the recommended protocol for tapering off Wellbutrin (bupropion) and starting Venlafaxine (venlafaxine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Wellbutrin (Bupropion) to Venlafaxine

Taper bupropion by reducing the dose by 10% of the most recent dose every 5-7 days until discontinuation, then initiate venlafaxine at 37.5 mg once or twice daily after a washout period is not required since these medications do not interact significantly. 1

Bupropion Discontinuation Protocol

Tapering Strategy

  • Reduce the dose by increments of the initial dose every 5-7 days until complete discontinuation 1
  • For example, if taking 150 mg twice daily (300 mg total):
    • Week 1: Reduce to 150 mg once daily
    • Week 2: Reduce to 75 mg once daily (if available) or 150 mg every other day
    • Week 3: Discontinue 1
  • The taper should take 10-14 days minimum to limit withdrawal symptoms 1

Managing Withdrawal Symptoms

  • Bupropion withdrawal is generally mild compared to serotonergic antidepressants, but patients may experience fatigue, mood changes, or irritability 2
  • If withdrawal symptoms occur, return to the previous well-tolerated dose and slow the taper rate 2
  • Consider symptomatic treatment with acetaminophen or NSAIDs for any muscle aches 1

Initiating Venlafaxine

Starting Dose

  • Begin venlafaxine at 37.5 mg once or twice daily 1
  • No washout period is required between bupropion and venlafaxine as they work through different mechanisms (bupropion affects dopamine/norepinephrine via different pathways than venlafaxine's serotonin/norepinephrine reuptake inhibition) 1

Titration Schedule

  • Increase by 75 mg each week as tolerated 1
  • Target therapeutic dose is typically 150-225 mg/day 1
  • Maximum dose is 225 mg/day 1
  • Allow 2-4 weeks to reach an efficacious dosage 1

Monitoring During Titration

  • Monitor blood pressure, as venlafaxine can cause dose-dependent increases 1
  • Prescribe with caution in patients with cardiac disease due to potential cardiac conduction abnormalities 1
  • Assess for common side effects including nausea, sweating, tremors, nervousness, insomnia or somnolence, dizziness, and gastrointestinal disturbances 1

Cross-Titration Approach (Alternative Strategy)

You can overlap the medications during the transition rather than completing the bupropion taper first:

  • Start venlafaxine at 37.5 mg daily while maintaining current bupropion dose 1
  • After 3-7 days, begin reducing bupropion by 10% increments every 5-7 days 1
  • Simultaneously increase venlafaxine by 37.5-75 mg weekly as tolerated 1
  • This approach may minimize any gap in antidepressant coverage and reduce withdrawal risk 2

Critical Pitfalls to Avoid

  • Never abruptly discontinue bupropion, even though its withdrawal syndrome is milder than SSRIs/SNRIs - this can still cause significant distress and missed work days 2
  • Do not rush the venlafaxine titration - it requires 2-4 weeks minimum to reach therapeutic doses, and faster titration increases side effects 1
  • Remember that venlafaxine itself requires careful tapering when eventually discontinued due to its short half-life and well-documented withdrawal syndrome 1, 2
  • Do not abandon the patient during this transition - close monitoring and support are essential, with clinician availability to manage symptoms and address fears 1

Patient Education

  • Inform patients that withdrawal symptoms from bupropion, if they occur, are typically mild and self-limiting 2
  • Explain that venlafaxine may take 4-6 weeks at therapeutic doses to show full antidepressant effects 1
  • Reassure patients that symptoms are usually transient and can be managed by adjusting the taper rate 2
  • Advise taking the second dose of venlafaxine before 3 p.m. if using twice-daily dosing to minimize insomnia risk 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.